vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and NNN REIT, INC. (NNN). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $240.4M, roughly 1.5× NNN REIT, INC.). NNN REIT, INC. runs the higher net margin — 39.1% vs -0.8%, a 39.9% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 4.1%). Over the past eight quarters, NNN REIT, INC.'s revenue compounded faster (5.3% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
NNN Reit, Inc. is a real estate investment trust that invests primarily in restaurant properties that are subject to long-term triple net leases, usually under leaseback arrangements. It is organized in Maryland with its principal office in Orlando, Florida.
ASIX vs NNN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $240.4M |
| Net Profit | $-2.8M | $94.0M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 61.0% |
| Net Margin | -0.8% | 39.1% |
| Revenue YoY | 9.4% | 4.1% |
| Net Profit YoY | -892.9% | -2.6% |
| EPS (diluted) | $-0.11 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $240.4M | ||
| Q4 25 | $359.9M | $238.4M | ||
| Q3 25 | $374.5M | $230.2M | ||
| Q2 25 | $410.0M | $226.8M | ||
| Q1 25 | $377.8M | $230.9M | ||
| Q4 24 | $329.1M | $218.5M | ||
| Q3 24 | $398.2M | $218.6M | ||
| Q2 24 | $453.5M | $216.8M |
| Q1 26 | — | $94.0M | ||
| Q4 25 | $-2.8M | $96.0M | ||
| Q3 25 | $-2.6M | $96.8M | ||
| Q2 25 | $31.4M | $100.5M | ||
| Q1 25 | $23.3M | $96.5M | ||
| Q4 24 | $352.0K | $97.9M | ||
| Q3 24 | $22.3M | $97.9M | ||
| Q2 24 | $38.9M | $106.7M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — |
| Q1 26 | — | 61.0% | ||
| Q4 25 | -0.7% | 62.3% | ||
| Q3 25 | -0.9% | 64.0% | ||
| Q2 25 | 7.7% | 66.0% | ||
| Q1 25 | 7.7% | 62.3% | ||
| Q4 24 | -3.9% | 65.8% | ||
| Q3 24 | 7.5% | 65.7% | ||
| Q2 24 | 11.5% | 70.2% |
| Q1 26 | — | 39.1% | ||
| Q4 25 | -0.8% | 40.2% | ||
| Q3 25 | -0.7% | 42.1% | ||
| Q2 25 | 7.7% | 44.3% | ||
| Q1 25 | 6.2% | 41.8% | ||
| Q4 24 | 0.1% | 44.8% | ||
| Q3 24 | 5.6% | 44.8% | ||
| Q2 24 | 8.6% | 49.2% |
| Q1 26 | — | $0.50 | ||
| Q4 25 | $-0.11 | $0.51 | ||
| Q3 25 | $-0.10 | $0.51 | ||
| Q2 25 | $1.15 | $0.54 | ||
| Q1 25 | $0.86 | $0.51 | ||
| Q4 24 | $0.02 | $0.52 | ||
| Q3 24 | $0.82 | $0.53 | ||
| Q2 24 | $1.43 | $0.58 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $4.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $4.4B |
| Total Assets | $1.7B | $9.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $4.6M | ||
| Q4 25 | $19.8M | $5.0M | ||
| Q3 25 | $23.7M | $157.9M | ||
| Q2 25 | $18.4M | $6.0M | ||
| Q1 25 | $8.3M | $5.1M | ||
| Q4 24 | $19.6M | $8.7M | ||
| Q3 24 | $17.3M | $173.5M | ||
| Q2 24 | $12.1M | $2.1M |
| Q1 26 | — | $4.4B | ||
| Q4 25 | $815.2M | $4.4B | ||
| Q3 25 | $818.2M | $4.4B | ||
| Q2 25 | $823.7M | $4.4B | ||
| Q1 25 | $794.4M | $4.4B | ||
| Q4 24 | $774.6M | $4.4B | ||
| Q3 24 | $766.4M | $4.4B | ||
| Q2 24 | $746.6M | $4.2B |
| Q1 26 | — | $9.4B | ||
| Q4 25 | $1.7B | $9.4B | ||
| Q3 25 | $1.7B | $9.5B | ||
| Q2 25 | $1.6B | $9.1B | ||
| Q1 25 | $1.6B | $9.0B | ||
| Q4 24 | $1.6B | $8.9B | ||
| Q3 24 | $1.5B | $8.9B | ||
| Q2 24 | $1.5B | $8.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $667.1M | ||
| Q3 25 | $26.6M | $218.3M | ||
| Q2 25 | $21.1M | $119.4M | ||
| Q1 25 | $11.4M | $203.3M | ||
| Q4 24 | $64.2M | $635.5M | ||
| Q3 24 | $57.3M | $206.6M | ||
| Q2 24 | $50.2M | $120.5M |
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.95× | ||
| Q3 25 | — | 2.25× | ||
| Q2 25 | 0.67× | 1.19× | ||
| Q1 25 | 0.49× | 2.11× | ||
| Q4 24 | 182.29× | 6.49× | ||
| Q3 24 | 2.57× | 2.11× | ||
| Q2 24 | 1.29× | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
NNN
Segment breakdown not available.
